OSCR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OSCR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Oscar Health's Accounts Payable & Accrued Expense for Financial Companies for the quarter that ended in Mar. 2024 was $2,646 Mil.
Oscar Health's quarterly Accounts Payable & Accrued Expense for Financial Companies increased from Sep. 2023 ($1,729 Mil) to Dec. 2023 ($2,084 Mil) and increased from Dec. 2023 ($2,084 Mil) to Mar. 2024 ($2,646 Mil).
Oscar Health's annual Accounts Payable & Accrued Expense for Financial Companies increased from Dec. 2021 ($1,513 Mil) to Dec. 2022 ($2,883 Mil) but then declined from Dec. 2022 ($2,883 Mil) to Dec. 2023 ($2,084 Mil).
The historical data trend for Oscar Health's Accounts Payable & Accrued Expense for Financial Companies can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Accounts Payable & Accrued Expense for Financial Companies | 887.70 | 1,371.60 | 1,513.21 | 2,882.87 | 2,083.95 |
Oscar Health Quarterly Data | ||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Accounts Payable & Accrued Expense for Financial Companies | Get a 7-Day Free Trial | 2,804.69 | 2,906.35 | 1,728.96 | 2,083.95 | 2,646.31 |
Accounts Payable & Accrued Expense for Financial Companies includes all current payables expected to be paid within one year or one operating cycle and accrued expenses.
Thank you for viewing the detailed overview of Oscar Health's Accounts Payable & Accrued Expense for Financial Companies provided by GuruFocus.com. Please click on the following links to see related term pages.
Alessandrea C. Quane | officer: EVP, Chief Insurance Officer | 175 WATER STREET, NEW YORK NY 10038 |
Richard Scott Blackley | officer: Chief Financial Officer | 1680 CAPITAL ONE DRIVE, MCLEAN VA 22102 |
Ranmali Bopitiya | officer: EVP & Chief Legal Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Victoria Baltrus | officer: Chief Accounting Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Mario Schlosser | director, officer: Chief Executive Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Sid Sankaran | director, officer: Chief Financial Officer | 180 MAIDEN LANE, NEW YORK NY 10038 |
Alphabet Inc. | 10 percent owner | 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW CA 94043 |
Mark T Bertolini | director, officer: Chief Executive Officer | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
William Gassen | director | 75 VARICK STREET, 5TH FLOOR, NEW YORK CITY NY 10013 |
Laura W Lang | director | DIGITAS INC., 800 BOYLSTON STREET, BOSTON MA 02199 |
Dennis Weaver | officer: Chief Clinical Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Meghan V. Joyce | officer: Chief Operating Officer | THE BOSTON BEER COMPANY, INC., ONE DESIGN CENTER PL., STE. 850, BOSTON MA 02210 |
Thrive Partners Vii Growth Gp, Llc | 10 percent owner | 295 LAFAYETTE STREET, NEW YORK NY 10012 |
Joshua Kushner | director, 10 percent owner, officer: See Remarks | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Thrive Partners Vii Gp, Llc | 10 percent owner | 295 LAFAYETTE STREET, NEW YORK NY 10012 |
From GuruFocus
By Business Wire Business Wire • 01-09-2023
By Business Wire • 01-18-2024
By GuruFocus Research • 01-24-2024
By GuruFocus Research • 01-11-2024
By Business Wire • 12-20-2023
By Business Wire • 07-07-2023
By Business Wire Business Wire • 02-10-2023
By Business Wire • 11-20-2023
By GuruFocus Research • 01-11-2024
By GuruFocus Research • 11-07-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.